BDTX
Price
$2.31
Change
-$0.12 (-4.94%)
Updated
Jun 13 closing price
Capitalization
131.35M
58 days until earnings call
BEAM
Price
$17.06
Change
-$0.38 (-2.18%)
Updated
Jun 13 closing price
Capitalization
1.72B
58 days until earnings call
Interact to see
Advertisement

BDTX vs BEAM

Header iconBDTX vs BEAM Comparison
Open Charts BDTX vs BEAMBanner chart's image
Black Diamond Therapeutics
Price$2.31
Change-$0.12 (-4.94%)
Volume$567.77K
Capitalization131.35M
Beam Therapeutics
Price$17.06
Change-$0.38 (-2.18%)
Volume$1.42M
Capitalization1.72B
BDTX vs BEAM Comparison Chart
Loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. BEAM commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Hold and BEAM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (BDTX: $2.31 vs. BEAM: $17.06)
Brand notoriety: BDTX and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 53% vs. BEAM: 73%
Market capitalization -- BDTX: $131.35M vs. BEAM: $1.72B
BDTX [@Biotechnology] is valued at $131.35M. BEAM’s [@Biotechnology] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • BDTX’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, BDTX is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 5 TA indicator(s) are bullish while BEAM’s TA Score has 3 bullish TA indicator(s).

  • BDTX’s TA Score: 5 bullish, 5 bearish.
  • BEAM’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, BDTX is a better buy in the short-term than BEAM.

Price Growth

BDTX (@Biotechnology) experienced а -10.47% price change this week, while BEAM (@Biotechnology) price change was -8.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

BDTX is expected to report earnings on Aug 12, 2025.

BEAM is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($1.72B) has a higher market cap than BDTX($131M). BDTX YTD gains are higher at: 7.944 vs. BEAM (-31.210). BDTX has higher annual earnings (EBITDA): -78.44M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. BDTX (98.6M). BDTX has less debt than BEAM: BDTX (22.2M) vs BEAM (158M). BEAM has higher revenues than BDTX: BEAM (63.6M) vs BDTX (0).
BDTXBEAMBDTX / BEAM
Capitalization131M1.72B8%
EBITDA-78.44M-399.03M20%
Gain YTD7.944-31.210-25%
P/E Ratio38.50N/A-
Revenue063.6M-
Total Cash98.6M1.22B8%
Total Debt22.2M158M14%
TECHNICAL ANALYSIS
Technical Analysis
BDTXBEAM
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 5 days ago
76%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAOFX21.05-0.20
-0.94%
JPMorgan Global Allocation R4
FZROX20.72-0.25
-1.19%
Fidelity ZERO Total Market Index
MPGVX15.48-0.20
-1.28%
Mondrian Global Equity Value
ICTTX14.19-0.26
-1.80%
ICON Health and Information Tech Inv
VEVFX39.95-0.82
-2.01%
Vanguard Explorer Value Inv